Natixis’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.9K | Sell |
1,947
-179
| -8% | -$1.28K | ﹤0.01% | 922 |
|
2025
Q1 | $17.9K | Sell |
2,126
-172
| -7% | -$1.45K | ﹤0.01% | 851 |
|
2024
Q4 | $33.2K | Sell |
2,298
-437
| -16% | -$6.31K | ﹤0.01% | 898 |
|
2024
Q3 | $62.8K | Sell |
2,735
-147
| -5% | -$3.37K | ﹤0.01% | 762 |
|
2024
Q2 | $57.9K | Buy |
2,882
+314
| +12% | +$6.31K | ﹤0.01% | 764 |
|
2024
Q1 | $63.2K | Sell |
2,568
-61
| -2% | -$1.5K | ﹤0.01% | 792 |
|
2023
Q4 | $47.6K | Sell |
2,629
-139
| -5% | -$2.52K | ﹤0.01% | 808 |
|
2023
Q3 | $55.1K | Sell |
2,768
-7
| -0.3% | -$139 | ﹤0.01% | 802 |
|
2023
Q2 | $69.9K | Sell |
2,775
-625
| -18% | -$15.8K | ﹤0.01% | 809 |
|
2023
Q1 | $73.7K | Sell |
3,400
-213
| -6% | -$4.62K | ﹤0.01% | 795 |
|
2022
Q4 | $107K | Buy |
+3,613
| New | +$107K | ﹤0.01% | 809 |
|